MEDTECH ANNOUNCES THE SALE OF TWO NEW ROSA ROBOTIC SURGERY SYSTEMS IN THE UNITED STATES
Montpellier, France, December 07 2015 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, is pleased to announce the sale of two new ROSA™ robotic surgery systems in the United States. The sales were to Children's Hospital of Atlanta and Children's Hospital Colorado.
Children's Hospital of Atlanta (GA) is America's largest pediatric establishment, according to the 2013 figures of the public health information system. It treats approximately 2, 500 patients in neurology and neurosurgery every year, which is twice the national average[1]. The hospital is rated among the 10 best American pediatric hospitals for the quality of its healthcare by the magazine U.S. News & World Report.
Children's Hospital Colorado (Aurora, CO) is a private pediatric hospital and regional reference center for pediatric care, particularly for the treatment of epilepsy. This center is also rated among the 10 best American pediatric hospitals in terms of quality of its healthcare by U.S. News & World Report.
“These sales to renowned American pediatric establishments, including the largest center in the country, show, once again, the interest and the benefits of our surgical robots to the world's leading market for medical devices,” said Bertin Nahum, CEO and Founder of Medtech.
|
About MEDTECH Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment. In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada. In 2013, MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan. In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine. In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards. In 2015, MEDTECH received the “2016 Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan. |
[1] http://www.choa.org/Childrens-Hospital-Services/Neurosciences/Volumes-and-Outcomes
| MEDTECH | INVESTORS | PRESS EU | PRESS US |
| Christophe Sibillin | Corinne Puissant | Alexandra Prisa | Joanna Zimmermann |
| Chief Financial Officer | Tel: +33 (0)1 53 67 36 77 | Tel: +33(0)1 53 67 36 90 | Tel: +1 646-536-7006 |
| Tel: +33 (0)4 67 10 77 40 |
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-42400-201505-MEDTECH-Two-New-U-S-Sales_UK.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews
